Patents/Assignees

SHANDONG HUBBLE KISEN BIOLOGICAL TECHNONLOGY CO., Ltd.

1 patent in portfolio

US12054502utility2024
Multifunctional Immunity-targeted Micromolecule Anti-cancer Medicine Bestazomib (bestazomib) and Preparation Method and Application Thereof
0 cites